Search

Search Constraints

You searched for: Author/Creator Bharucha, Kamal N.

Search Results

1. A14: Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Systemic Juvenile Idiopathic Arthritis. Issue 11 (March 2014)

2. A14: Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Systemic Juvenile Idiopathic Arthritis. Issue Volume 66:Issue(2014)supplement 3 (March 2014)

3. A4: Efficacy and Safety of Tocilizumab in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: 2‐Year Data From CHERISH. Issue 11 (March 2014)

4. A4: Efficacy and Safety of Tocilizumab in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: 2‐Year Data From CHERISH. Issue Volume 66:Issue(2014)supplement 3 (March 2014)

5. Catch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial1. Issue 3 (March 2015)

6. Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial. Issue 3 (9th February 2021)